Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: Prospective comparison between 1.5-T and 3.0-T images in the same patients

European Radiology

Volumn 20, Issue 9, 2010, Pages 2265-2273

  Sofue, Keitaro ^a   Tsurusaki, Masakatsu ^a   Miyake, Mototaka ^a   Sakurada, Aine ^a   Arai, Yasuaki ^a   Sugimura, Kazuro ^b  

^a NATIONAL CANCER CENTER   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatic metastasis; Magnetic resonance imaging; Superparamagnetic iron oxide

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; ARTIFACT; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PREDICTIVE VALIDITY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

ADULT; AGED; CARCINOMA; CONTRAST MEDIA; DEXTRANS; FEMALE; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77957961415     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1798-3     Document Type: Article

References (36)

1. Norris DG (2003) High field human imaging. J Magn Reson Imaging 18:519-529
2. Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946-959
3. Hussain SM, Wielopolski PA, Martin DR (2005) Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future? Top Magn Reson Imaging 16:325-335
4. Merkle EM, Dale BM (2006) Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 186:1524-1532
5. Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3.0 T. Magn Reson Imaging Clin N Am 14:17-26
6. von Falkenhausen MM, Lutterbey G, Morakkabati-Spitz N et al (2006) High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 241:156-166
7. Akisik FM, Sandrasegaran K, Aisen AM, Lin C, Lall C (2007) Abdominal MR imaging at 3.0 T. Radiographics 27:1433-1444, discussion 1462-1464
8. Choi JY, Kim MJ, Chung YE et al (2008) Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system. Radiographics 28(4):e30
9. Retz CJ, Stark DD, Metz CE et al (1990) Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgeno 155:763-770
10. Seneterre E, Taourel P, Bouvier Y et al (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785-792
11. Strotzer M, Gmeinwieser J, Schmidt J et al (1997) Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 38:986-992
12. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson P (1999) Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210:459-466
13. Reimer P, Jähnke N, Fiebich M et al (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152-158
14. Vogl TJ, Schwarz W, Blume S et al (2003) Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist) - enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 13:262-272
15. Rappeport ED, Loft A (2007) Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging 32:624-634
16. Reimer P, Tombach B (1998) Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8:1198-1204
17. Balzer T, Carter EC, Shamsi K, Niendorf HP (1996) Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver. Acad Radiol 3 (Suppl 2): S417-S419
18. Onishi H, Murakami T, Kim T et al (2006) Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 239:131-138
19. Ward J, Robinson PJ, Guthrie JA et al (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology 237:170-180
20. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC (2006) Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 16:1337-1345
21. Benderbous S, Corot C, Jacobs P, Bonnemain B (1996) Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol 3 (Suppl 2): S292-S294
22. Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319-2331
23. von Falkenhausen M, Meyer C, Lutterbey G et al (2007) Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T. Eur Radiol 17:1256-1261
24. Chang JM, Lee JM, Lee MW et al (2006) Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions. Invest Radiol 41:168-174
25. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA (1989) Measuring signal-to-noise ratios in MR imaging. Radiology 173:265-267
26. Kumano S, Murakami T, Kim T et al (2003) Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. AJR Am J Roentgenol 181:1335-1339
27. Kanematsu M, Matsuo M, Yamada Y et al (2003) Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging 18:40-48
28. Landis JR, Koch GG (1997) The measurement of observer agrrement for categorical data. Biometrics 33:159-174
29. Park HS, Lee JM, Kim SH et al (2009) Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging 29:328-335
30. Yoo HJ, Lee JM, Lee MW et al (2008) Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, highresolution 3.0T-MR imaging with pathologic correlation. Invest Radiol 43:538-546
31. *-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems. J Magn Reson Imaging 29:595-600
32. Tanimoto A, Yuasa Y, Shinmoto H et al (2002) Superparamagnetic iron oxidemediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 222:661-666
33. Fretz CJ, Elizondo G, Weissleder R, Hahn PF, Stark DD, Ferrucci JT Jr (1989) Superparamagnetic iron oxideenhanced MR imaging: pulse sequence optimization for detection of liver cancer. Radiology 172:393-397
34. Ward J, Guthrie JA, Wilson D et al (2003) Colorectal hepatic metastases: detection with SPIO-enhanced breathhold MR imaging-comparison of optimized sequences. Radiology 228:709-718
35. Matsuo M, Kanematsu M, Itoh K et al (2004) Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs. AJR Am J Roentgenol 182:235-242
36. Kim MJ, Kim JH, Choi JY et al (2006) Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 187: W255-W266